Operating cash flow changed across a sign change
Operating cash flow changed +165.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow changed +165.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Operating income changed -101.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
R&D / revenue changed -1668 basis points from the comparable as-filed period.
Current liabilities changed -12.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current ratio changed +215.1% from the comparable as-filed period.
Operating cash-flow margin changed +32588 basis points from the comparable as-filed period.
Working capital / assets changed +1901 basis points from the comparable as-filed period.
Stock-based compensation changed -9.6% from the comparable as-filed period.
Research & development changed +8.9% from the comparable as-filed period.
Operating cash flow / net income changed +6932.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.